This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The 5 Dumbest Things on Wall Street This Week: April 13

3. Molina's Messy Monday

Hold everything! Stop the presses! The Buckeye state has produced yet another political casualty, and boy is this one a real knock-out blow.

We're not talking about Mitt Romney vanquishing his rival Rick Santorum in last month's Ohio Republican primary of course. Heck, that's ancient history at this point. No, we're referring to the state's Medicaid decisions which totally floored a once-prominent provider.

Seriously, forget "Super Tuesday." It was " Molina (MOH - Get Report) Monday" that was the real game changer this week.

Shares of Molina Healthcare sank almost 27% Monday after the state of Ohio neglected to include it on the list of companies selected to administer its Medicaid program for more than 1.5 million people. Also snubbed by the state was fellow provider Centene (CNC), which saw its stock drop 15.4% on the news.

Among the companies making the cut were Aetna Better Health of Ohio, CareSource, Meridian Health Plan, Paramount Advantage and United Healthcare Community Plan of Ohio. And to add insult to injury, Aetna and Meridian Health are new entrants to the Ohio program while the incumbent Molina, now mulling an appeal, has been in the state for years. Molina generated more than $1.2 billion in premiums in the state, or about 22% of the company's total revenue and reportedly 30% of its profits.

Perhaps Citigroup analyst Carl McDonald summed up Molina's situation best in his note to clients when he wrote, "Ouch."

Ouch indeed. We don't have to put that up for a vote.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BBY $37.21 -1.53%
MOH $66.31 -1.46%
NOK $7.55 -0.40%
SNE $27.26 1.79%
AAPL $124.25 -0.14%

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs